Legend Biotech Corp Income Tax Expense Continuing Operations
Legend Biotech Corp (LEGN) reported Income Tax Expense Continuing Operations of $14.20 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2026-03-10
- Legend Biotech Corp income tax expense continuing operations for the quarter ending 2025-12-31 was $11.22M, a 21.20% decline year-over-year.
- Legend Biotech Corp income tax expense continuing operations for the quarter ending 2025-09-30 was $616.00K, a 86.11% decline year-over-year.
- Legend Biotech Corp income tax expense continuing operations for the quarter ending 2025-06-30 was $582.00K, a 157.52% increase year-over-year.
- Legend Biotech Corp income tax expense continuing operations for the quarter ending 2025-03-31 was $1.79M, a 35620.00% increase year-over-year.
| Period end | Income Tax Expense Continuing Operations 3 month | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 9 month | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $11.22M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $11.83M derived: sum of 2 quarters · filed 2026-03-10 | $12.41M derived: sum of 3 quarters · filed 2026-03-10 | $14.20M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $616.00K 6-K · filed 2025-11-12 | $1.20M derived: sum of 2 quarters · filed 2025-11-12 | $2.98M 6-K · filed 2025-11-12 | $17.22M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | $582.00K 6-K · filed 2025-08-11 | $2.37M 6-K · filed 2025-08-11 | $16.60M derived: sum of 3 quarters · filed 2026-03-10 | $21.04M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $1.79M 6-K · filed 2025-05-13 | $16.02M derived: sum of 2 quarters · filed 2026-03-10 | $20.45M derived: sum of 3 quarters · filed 2026-03-10 | $20.68M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $14.23M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $18.67M derived: sum of 2 quarters · filed 2026-03-10 | $18.89M derived: sum of 3 quarters · filed 2026-03-10 | $18.90M 20-F · filed 2026-03-10 | $18.89M 20-F · filed 2025-03-11 |
| 2024-09-30 | $4.43M 6-K · filed 2025-11-12 | $4.66M derived: sum of 2 quarters · filed 2025-11-12 | $4.67M 6-K · filed 2025-11-12 | $2.64M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $226.00K 6-K · filed 2025-08-11 | $231.00K 6-K · filed 2025-08-11 | -$1.80M derived: sum of 3 quarters · filed 2026-03-10 | -$2.09M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $5.00K 6-K · filed 2025-05-13 | -$2.02M derived: sum of 2 quarters · filed 2026-03-10 | -$2.31M derived: sum of 3 quarters · filed 2026-03-10 | -$2.02M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | -$2.03M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$2.32M derived: sum of 2 quarters · filed 2026-03-10 | -$2.03M derived: sum of 3 quarters · filed 2026-03-10 | -$1.90M 20-F · filed 2026-03-10 | -$1.86M 20-F · filed 2024-03-19 |
| 2023-09-30 | -$288.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $2.00K derived: sum of 2 quarters · filed 2024-11-12 | $130.00K 6-K · filed 2024-11-12 | $283.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $290.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $418.00K 6-K · filed 2024-08-09 | $571.00K derived: sum of 3 quarters · filed 2025-03-11 | $723.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $128.00K 6-K · filed 2024-05-13 | $281.00K derived: sum of 2 quarters · filed 2025-03-11 | $433.00K derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | $153.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $305.00K derived: sum of 2 quarters · filed 2025-03-11 | $625.00K 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $152.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $472.00K 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $320.00K 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | -$3.61M 20-F · filed 2024-03-19 | $1.00K 20-F · filed 2022-03-31 | |||
| 2021-06-30 | $1.00K 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | -$41.91M 20-F · filed 2023-03-30 | -$4.14M 20-F · filed 2021-04-02 | |||
| 2020-06-30 | -$3.71M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | -$25.73M 20-F/A · filed 2023-02-17 | $2.60M 20-F · filed 2021-04-02 | |||
| 2018-12-31 | $1.17M 20-F · filed 2021-04-02 |